From: Post-stroke fatigue: The role of comorbidities and its impact on quality of life
Demographic variables | Responders (n = 142) | Non-responders (n = 188) | p value a | |
---|---|---|---|---|
N (%) or mean (SD) | N (%) or mean (SD) | |||
Sex, male | 83 (58.5) | 111 (59.0) | 0.91 | |
Age, years | 74.8 (9.7) | 74.3 (13.9) | 0.70 | |
Time since first stroke, years | 8.0 (7.9) | 8.6 (7.1) | 0.48 | |
Stroke type | Ischemic | 121 (85.2) | 160 (85.1) | 0.98 |
Hemorrhagic | 21 (14.8) | 28 (14.9) | ||
Comorbidities and residual stroke symptoms | ||||
Diabetes mellitus | 40 (28.2) | 51 (27.1) | 0.83 | |
Orthopedic disorders | 42 (29.6) | 58 (30.9) | 0.80 | |
Vertigo | 29 (20.4) | 32 (17.0) | 0.43 | |
Ischemic heart disease | 22 (15.5) | 36 (19.1) | 0.39 | |
Cognitive impairment | 7 (4.9) | 33 (17.6) | < 0.001 | |
Psychiatric disorders | 12 (8.5) | 23 (12.2) | 0.27 | |
Chronic pulmonary disorders | 15 (10.6) | 12 (6.4) | 0.17 | |
Hemiparesis | 26 (18.3) | 51 (27.1) | 0.06 | |
Aphasia | 9 (6.3) | 25 (13.3) | 0.04 |